#SCREEN MARKER TOO SLOW UPDATE#
#SCREEN MARKER TOO SLOW FULL#
#SCREEN MARKER TOO SLOW ANDROID#

I am using Svg to draw marker at Android and View to draw one at Is this still relevant with the latest version? Now google map at android response very very fast. In fact any child in the Marker component cases lag. The following marker causes extreme lag on android. To compare, changing the SVG image to a png in the image prop fixes the lag problem but would be unusable in all but the most basic use cases. Below is an example of a circle marker (I use more complex markers but even this will result in the same slow down). Spinner animations become clunky and the map becomes almost unusable as complex gestures aren't registered. After updating expo and rn maps even navigating away from the map will cause delays of 5-10 seconds to register a click. In previous versions my app functioned well on android and iOS. If the map initialises with more than 10 markers the entire app runs extremely slow on android (only appears to effect android).

#SCREEN MARKER TOO SLOW FULL#

My main page is a full screen mapview with about 10-100 custom markers. In that time expo updated rn maps from 0.21.0 to 0.22.1. This has only been an issue since updating Expo SDK from 30 to SDK 32. 'react-native-svg': 8.0.10 Steps to Reproduce 48(8):1151-9.Yes Have you read the Installation Instructions? Practice guidelines for tumor marker use in the clinic. A Predictor of Early Disease Recurrence in Patients With Breast Cancer Using a Cell-free RNA and Protein Liquid Biopsy. Lasham A, Fitzgerald SJ, Knowlton N, et al. An individual reference limit of the serum CEA-TPA-CA 15-3 tumor marker panel in the surveillance of asymptomatic women following surgery for primary breast cancer. Correlation between Cancer Antigen 15.3 Value and Qualitative and Semi-quantitative Parameters of Positron Emission Tomography/Computed Tomography in Breast Cancer patients. 53(4):131-8.Ĭervino AR, Saibene T, Michieletto S, Ghiotto C, Bozza F, Saladini G, et al. Factors influencing the area under the ROC curve. CA 15.3 measurements for separating FDG PET/CT positive from negative findings in breast carcinoma recurrence. Kruse V, Van de Wiele C, Borms M, Maes A, Pottel H, Sathekge M, et al. Intensive post-operative follow-up of breast cancer patients with tumour markers: CEA, TPA or CA15.3 vs MCA and MCA-CA15.3 vs CEA-TPA-CA15.3 panel in the early detection of distant metastases. Ca 15-3 in the follow-up of localised breast cancer: a prospective study. Nipple discharge of CA15-3, CA125, CEA and TSGF as a new biomarker panel for breast cancer. Wang G, Qin Y, Zhang J, Zhao J, Liang Y, Zhang Z, et al. Serum CEA and CA 15-3 as prognostic factors in primary breast cancer. 2014 Aug 16.Įbeling FG, Stieber P, Untch M, Nagel D, Konecny GE, Schmitt UM. Designing a recombinant chimeric construct contain MUC1 and HER2 extracellular domain for prediagnostic breast cancer. Gheybi E, Amani J, Salmanian AH, Mashayekhi F, Khodi S.

#SCREEN MARKER TOO SLOW UPDATE#

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. Harris L, Fritsche H, Mennel R, Norton L, Ravdin P, Taube S. MUC1 gene-derived glycoprotein assays for monitoring breast cancer (CA 15-3, CA 27.29, BR): are they measuring the same antigen?.

CA 15-3: a prognostic marker in breast cancer. 19(1):17-26.ĭuffy MJ, Shering S, Sherry F, McDermott E, O'Higgins N. Expression of monoclonal antibody-defined tumor markers in four carcinomas. Clinical and technical evaluation of ACS™BR serum assay of MUC1 gene-derived glycoprotein in breast cancer, and comparison with CA 15-3 assays. Detection of secondary metastatic breast cancer by measurement of plasma CA 15.3.

Screen marker too slow